Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

West Pharmaceutical Services Inc. buy UBS Group AG

Start price
€226.50
25.07.25 / 50%
Target price
€272.54
25.07.26
Performance (%)
27.42%
End price
-
02:15
Summary
This prediction is currently being closed. The BUY prediction by UBS_Group_AG currently has a performance of 27.42%. UBS_Group_AG has a follow-up prediction for West Pharmaceutical Services Inc. where he still thinks West Pharmaceutical Services Inc. is a Buy. UBS_Group_AG has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
West Pharmaceutical Services Inc. -7.884% -7.884% 21.362%
iShares Core DAX® 0.855% 1.375% 2.609%
iShares Nasdaq 100 -0.989% -3.844% 25.552%
iShares Nikkei 225® -1.781% -8.530% 42.813%
iShares S&P 500 0.057% 0.610% 21.574%

Comments by UBS_Group_AG for this prediction

In the thread West Pharmaceutical Services Inc. diskutieren
Prediction Buy
Perf. (%) 27.42%
Target price 272.544
Change
Ends at 25.07.26

West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at UBS Group AG from $285.00 to $320.00. They now have a "buy" rating on the stock.
Ratings data for WST provided by MarketBeat

In the thread Trading West Pharmaceutical Services Inc.
Prediction Buy
Perf. (%) 27.42%
Target price 272.544
Change
Ends at 25.07.26

Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten

Current prediction by UBS_Group_AG for West Pharmaceutical Services Inc.

buy
West Pharmaceutical Services Inc.

Start price
Target price
Perf. (%)
€208.70
13.02.26
-
13.02.27
38.28%
24.07.26

Stopped prediction by UBS_Group_AG for West Pharmaceutical Services Inc.

buy
West Pharmaceutical Services Inc.

Start price
Target price
Perf. (%)
€310.00
12.12.24
€372.22
12.12.25
-27.03%
13.12.25